Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

You may be eligible if

• Arm 1 (healthy controls):
• Healthy participants,
• Non-smoker,
• Age 20-65 years
• Arm 2 (patients with depression):
• Diagnosis of major depression (DSM-V),
• Selective Serotonin-Reuptake-Inhibitor (SSRI) or Selective Serotonin-Noradrenalin-Reuptake-Inhibitor (SSNRI) medication,
• Age 20-65 years